NF-κB inhibitory action of resveratrol: A probable mechanism of neuroprotection in experimental diabetic neuropathy

Vinik, 2004, Diabetic neuropathies, Med. Clin. North Am., 88, 947, 10.1016/j.mcna.2004.04.009 Zhao, 2010, Prevalence of other diabetes-associated complications and comorbidities and its impact on health care charges among patients with diabetic neuropathy, J. Diabetes Complications, 24, 9, 10.1016/j.jdiacomp.2008.09.001 Kumar, 2007, Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy, Life Sci., 80, 1236, 10.1016/j.lfs.2006.12.036 Sayyed, 2006, Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy, Life Sci., 79, 777, 10.1016/j.lfs.2006.02.033 Negi, 2010, Functional and biochemical evidence indicating beneficial effect of Melatonin and Nicotinamide alone and in combination in experimental diabetic neuropathy, Neuropharmacology, 58, 585, 10.1016/j.neuropharm.2009.11.018 Sharma, 2008, Protective effects of 4-amino1,8-napthalimide, a poly (ADP-ribose) polymerase inhibitor in experimental diabetic neuropathy, Life Sci., 82, 570, 10.1016/j.lfs.2007.11.031 Laura, 2006, Immunolocalization and activation of nuclear factor-kappaB in the sciatic nerves of rats with experimental autoimmune neuritis, J. Neuroimmunol., 174, 32, 10.1016/j.jneuroim.2006.01.004 Ho, 1999, Antioxidants, NFkappaB activation, and diabetogenesis, Proc. Soc. Exp. Biol. Med., 222, 205, 10.1046/j.1525-1373.1999.d01-137.x Cameron, 2008, Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway, Curr. Drug Targets, 9, 60, 10.2174/138945008783431718 Sousa, 2000, Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-κB) activation, Lab. Invest., 80, 1101, 10.1038/labinvest.3780116 Andorfer, 2001, Expression and distribution of transcription factor NF-kappaB and inhibitor IkappaB in the inflamed peripheral nervous system, J. Neuroimmunol., 116, 226, 10.1016/S0165-5728(01)00306-X Karin, 2004, The IKK NF-kappa B system: a treasure trove for drug development, Nat. Rev. Drug Discov., 3, 17, 10.1038/nrd1279 Baur, 2006, Resveratrol improves health and survival of mice on a high-calorie diet, Nature, 444, 337, 10.1038/nature05354 Zhu, 2008, Anti-inflammatory effect of resveratrol on TNF-alpha-induced MCP-1 expression in adipocytes, Biochem. Biophys. Res. Commun., 369, 471, 10.1016/j.bbrc.2008.02.034 Sharma, 2009, Neuroprotective potential of combination of resveratrol and 4-amino 1,8 naphthalimide in experimental diabetic neuropathy: focus on functional, sensorimotor and biochemical changes, Free Radic. Res., 43, 400, 10.1080/10715760902801509 Ohkawa, 1979, Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction, Anal. Biochem., 95, 351, 10.1016/0003-2697(79)90738-3 Kim, 2005, Role of p38 MAPK in UVB-induced inflammatory responses in the skin of SKH-1 hairless mice, J. Invest. Dermatol., 124, 1318, 10.1111/j.0022-202X.2005.23747.x Lehmann, 2008, LPS induces the TNF-alpha-mediated downregulation of rat liver aquaporin-8: role in sepsis-associated cholestasis, Am. J. Physiol. Gastrointest. Liver Physiol., 294, G567, 10.1152/ajpgi.00232.2007 Obrosova, 2004, Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy, Diabetes, 53, 711, 10.2337/diabetes.53.3.711 Negi, 2010, Concurrent targeting of nitrosative stress-PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathy, Biochem. Biophys. Res. Commun., 391, 102, 10.1016/j.bbrc.2009.11.010 Leonard, 2003, Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses, Biochem. Biophys. Res. Commun., 309, 1017, 10.1016/j.bbrc.2003.08.105 Yamamoto, 2001, Role of the NF-kappaB pathway in the pathogenesis of human disease states, Curr. Mol. Med., 1, 287, 10.2174/1566524013363816 Singh, 2010, Resveratrol (trans-3,5,4′-trihydroxystilbene) induces SIRT1 and down-regulates NF-{kappa}B activation to abrogate DSS-induced colitis, J. Pharmacol. Exp. Ther., 332, 829, 10.1124/jpet.109.160838 Manna, 2000, Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation, J. Immunol., 164, 6509, 10.4049/jimmunol.164.12.6509 Bujalska, 2008, Effect of cyclooxygenase and nitric oxide synthase inhibitors on streptozotocin-induced hyperalgesia in rats, Pharmacology, 81, 151, 10.1159/000110787 Kellogg, 2007, Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes, Diabetes, 56, 2997, 10.2337/db07-0740